top of page

Free Biopharma Daily Stock Updates - 08/31/21

$XBI $132.84 +0.92%

 

Pipeline Updates

$EGRX +10.2% Eagle Pharmaceuticals Wins Vasopressin Patent Trial. source


$PSTX -19.3% Poseida Therapeutics Presents Preliminary Results from Phase 1 Trial of P-PSMA-101 at the 6th Annual CAR-TCR Summit. source


$JAZZ +0.1% Jazz Pharmaceuticals Announces Health Canada Approval of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea. source


$ACIU +16.3% AC Immune Announces First Positive Cognitive Results for a Tau-Targeting Monoclonal Antibody in Alzheimer’s Disease. source


$CYTK +1.0% Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF to Be Presented in Late Breaking Clinical Trials Session at the HFSA Annual Scientific Meeting. source


$AMRN -1.8% Amarin Reports Overview of Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) and Eicosapentaenoic Acid (EPA) Presented at ESC Congress 2021, Organized by the European Society of Cardiology. source


$EGRX +10.2% Eagle Pharmaceuticals Granted Additional Patent for Bendamustine Franchise. source


$GMTX 20.9% Gemini Therapeutics Announces Presentation of Previously Released Data from Its Ongoing Phase 2a Study of GEM103 at Clinical Trials at the Summit. source


$VLON +24.0%



Market Updates

$ASND +1.6% Ascendis Pharma A/S Announces Proposed Public Offering of ADSs. source


$VECT +18.3% VectivBio to Acquire Comet Therapeutics and Host R&D Day. source


 

Posted by FS

0 comments
bottom of page